Activated thrombin activatable fibrinolysis inhibitor levels are associated with the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples